Delivery Order SPE2DB25D3003-SPE2DB25FPXBR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,830.02 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's larger indefinite delivery vehicle with the DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,841.26 to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count supply). This is a firm fixed price contract with no set-aside designation, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. Mesalamine is a gastrointestinal anti-inflammatory medication used to treat conditions such as...
- The Defense Logistics Agency awarded a $1,724.60 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any particular business category and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,489.23 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed price arrangement. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 5, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a $3,525.60 delivery order to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.72 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location. This...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXBRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,922.67 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with a firm fixed price structure. The contract is non-competitive and represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies this medication as part of its extensive portfolio supporting military and veteran healthcare systems. Mesalamine, commonly used for inflammatory bowel disease treatment, falls within the company's demonstrated capability to deliver brand-name and generic pharmaceuticals across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support Medical contract vehicle enables flexible pharmaceutical procurement to support military healthcare programs globally, with AmerisourceBergen positioned as a primary supplier alongside anticipated competitors in the Department of Defense's upcoming Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 9/2/25 |